FDA Investigator Nancy M Espinal

Nancy M Espinal has inspections in 7 countries as of 03 Nov 2023. Nancy M Espinal has collaborated with a combinined 4390 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

03 Nov 2023

Investigator Role:

FDA Investigator

Redica ID:

100000698

Country:

United States of America, India, Belgium, Korea (Republic of), China, France

Co-Investigator(s):

Addam S Reynolds, Adetutu M Gidado, Alicia M Mozzachio, Alison N Stieg, Amy C Jordan, Amy Chen, Amy L Singer, Amy M Cramer, Amy N Chen, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Andrew J Barrowcliff, Andrew M Barlow, Ankur C Patel, Annemarie B Randow, Annemarie Bodnar, Atul J Agrawal, Azza Talaat, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Bijoy Panicker, Brandy N Lepage, Brenna L Macdowell, Brooke K Higgins, Brooke K Seeman, Bryan L Mcguckin, Byungja E Marciante, Byungja E Mercuente, Byungja H Marciante, Carl A Anderson, CDR Ileana Barreto Pettit, Chaltu N Wakijra, Charanjeet Jassal, Charles R Cote, RIC, Christopher R Czajka, Constantin Y Philopoulos, Daniel J Grabicki, Daniel J Min, Daniel L Obrzut, David A Carlson, David A Oluwo, David R Heiar, Dawa L Wydner, Dawn L Wydner, Dawn L Wyndver, Denise M Visco, Investigator, Dennis Cantellops Paite, Dennis L Doupnik, Devon Jenkins, Dhaval H Patel, Diane C Thibodeau, Diane T Bargo, Diane T O'brien, Donald L Lech, Doreen P Gubbay, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Robert C Horan, MD, Elaine E Gilfillan, Emest F Bizjak, Emmanuel J Ramos, Eric Rothschild, Erik W Koester, Erika V Butler, Erin D Mccaffery, Esteban Beltran, Farhana Khan, Frank J Marciniak, Frederick Razzaghi, George J Flynn, Gianine E Tompkins, Guerlain Ulysse, Helen Verdel, Himanshu Gupta, PhD, Jaison J Eapen, James C Maclaughlin, James D Bridges, James M Mason, James R Birkenstamm, Janet A Rajan, Jason K Morgan, Jay T Wong, Jean M Kelahan, Jennifer L Huntington, Jennifer Macmillan, Jeremy W Rotton, Jessica M Monteiro, Jessica S Estriplet, Joanne M Schlossin, Jogy George, John P Mistler, Johnna L Bleem, Jonathan G Matrisciano, Jonathan W Chapman, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph J Vannelli, Joseph Mcginnis, Joy R Kozlowski, Joy Rkozlowski Klena, Juanita P Versace, June P Page, Junho Pak, Justin A Boyd, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Karen F Tomaziefski, Karen L Kosar, Karishma G Gopaul, Katelyn Astaub Zamperini, Katherine Szestypalow, Kelli F Dobilas, Kellia N Hicks, Kenneth R Merritt, Kevin P Foley, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Krystyna M Kitson, Kshitij A Patkar, Lata C Mathew, PhD, Laura L Staples, Lauren L Vajo, Lawrence Harmon, Jr, Lawrence J Stringer, Liatte Kreuger, PharmD, Lisa M Bellows, Loretta Nemchik, Luella J Rossi, Luis A Dasta, Marcelo O Mangalindan, Jr, Marcus A Ray, Marea K Harmon, Margaret M Sands, Maria Estrella, Marie F Morin, Massoud Motamed, Matthew D Schnittker, Melissa A Freeman, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Melkamu Getie Kebtie, PhD, Meredith L Sheridan, Meyer J Slobotsky, Meyer J Sobotsky, Michael A Taylor, Michael L Chasey, Michael R Goga, Michael R Klapal, Michael Serrano, Michael W Burd, Michele Gottshall, Michelle Marsh, Mindy M Chou, Monica Cburgos Garcia, Monika Borkowska, Muralidhara B Gavini, PhD, Nancy F Scheraga, Nancy L Rolli, Nancy Sheraga, Natasha Gupta, Nerizza B Dalena, Nerizza B Guerin, Nicholas A Violand, Nije A Thomas, Niketa Patel, Nikisha M Bolden, Nikki S Ramirez, Nina Ni, Nina Yang, Pal S Mayasandra, Pankaj H Amin, Patrick C Klotzbuecher, Paul L Bellamy, Paula J Bretz, Philip Kreiter, Pratik S Upadhyay, DDC, Pushpa S Jayasekara, Puspa Suresh Jayasekara, Qin Xu, Rabin N Ghoshal, Rachael O Oyewole, Rajiv R Srivastava, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard K Glabach, Rita K Kabaso, Robert D Tollefsen, Robert J Martin, Robert Mo Brien, Robert W Calais, Robin P Mathew, Rochelle L Cross, Rosario D'costa, Rose Ljean Mary, Russell J Glapioin, Russell J Glapion, Saleem A Akhtar, Sandra A Boyd, Sarah Adella Fave, Sarah Forney, Sayyem H Akbar, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Sherry G Bous, Shirley S Wen, Sneha Patel, Sneha S Patel, Sony Mathews, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Steven M Weinman, Steven P Donald, Susan M Jackson, Syeda N Mahazabin, Tamika White, Tamil Arasu, PhD, Tara G Bizjak, Thomas J Arista, Thomas P Hansen, Timothy T Kapsala, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Unnee Ranjan, Vivin George, William A Warnick, William J Muszynski, William L Bargo, William R Chang, Xikui Chen (nmi), PhD, Yvesna C Blaise, Yvins Dezan, Zhongren Wu

Nancy M Espinal's Documents

Publish Date	Document Type	Title
April, 2016	FDA 483 Response	Akorn Operating Company LLC (dba Akorn) - Form 483R, 2016-04-26
February, 2017	FDA 483	Novel Laboratories, Inc. - Form 483, 2017-02-14
December, 2018	EIR	Siegfried USA, LLC - EIR, 2018-12-19
June, 2017	EIR	C. O. Truxton Inc. - EIR, 2017-06-01
January, 2018	FDA 483	Veranova, L.P. - Form 483, 2018-01-31
July, 2016	FDA 483	Actavis LLC - Form 483, 2016-07-07
January, 2018	FDA 483 Response	Veranova, L.P. - Form 483R, 2018-02-21
July, 2016	EIR	Actavis LLC - EIR, 2016-07-07
September, 2019	EIR	AptaPharma Inc. - EIR, 2019-10-23
October, 2017	EIR	Teligent, Inc. - EIR, 2017-10-19
July, 2019	FDA 483	Mandell's Clinical Pharmacy - Form 483, 2019-07-25
June, 2016	FDA 483	Village Pharmacy - Form 483, 2016-06-22
April, 2016	FDA 483	Alliance Technologies, LLC - Form 483, 2016-04-15
June, 2017	FDA 483	C. O. Truxton Inc. - Form 483, 2017-06-01
October, 2019	FDA 483	SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH - Form 483, 2019-10-22
August, 2017	FDA 483 Response	Novel Laboratories, Inc. - Form 483R, 2017-11-30
August, 2019	EIR	Specialty Minerals Incorporated - EIR, 2019-08-22
August, 2017	FDA 483	Novel Laboratories, Inc. - Form 483, 2017-08-08
September, 2019	FDA 483	AptaPharma Inc. - Form 483, 2019-09-25
October, 2021	FDA 483	Symed Labs Limited - Form 483, 2021-10-16
April, 2016	FDA 483	Akorn Operating Company LLC (dba Akorn) - Form 483, 2016-04-04
January, 2018	EIR	Veranova, L.P. - EIR, 2018-01-31
October, 2017	FDA 483 Response	Teligent, Inc. - Form 483R, 2018-02-06
August, 2019	FDA 483	Specialty Minerals Incorporated - Form 483, 2019-08-22
December, 2015	FDA 483	L'OREAL USA, INC. - Form 483, 2015-12-09
May, 2019	FDA 483 Response	Teligent, Inc. - Form 483R, 2019-11-11
December, 2015	EIR	The Jet Pulverizer Company - EIR, 2015-12-21
August, 2021	FDA 483	Teligent, Inc. - Form 483, 2021-08-31
August, 2019	FDA 483	CooperSurgical, Inc. - Form 483, 2019-08-01
November, 2016	FDA 483	InvaTech Pharma Solutions LLC - Form 483, 2016-11-08
December, 2018	FDA 483	Siegfried USA, LLC - Form 483, 2018-12-19
August, 2017	FDA 483	Mylan Pharmaceuticals Inc. - Form 483, 2017-08-25
November, 2019	FDA 483	TENTAMUS INDIA PRIVATE LIMITED - Form 483, 2019-11-01
March, 2016	FDA 483	SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2016-03-14
October, 2017	FDA 483	Teligent, Inc. - Form 483, 2017-10-19
September, 2021	FDA 483	LUPIN LIMITED - Form 483, 2021-09-18
October, 2020	FDA 483	Curexa - East, LLC dba Curexa - Form 483, 2020-10-09
November, 2018	FDA 483	Shiseido America Inc. - Form 483, 2018-11-01
October, 2021	FDA 483	DR.REDDY'S LABORATORIES LIMITED - Form 483, 2021-10-29
December, 2022	FDA 483	CIS Bio International - Form 483, 2022-12-16
December, 2018	FDA 483 Response	Siegfried USA, LLC - Form 483R, 2019-01-10
July, 2016	FDA 483 Response	Actavis LLC - Form 483R, 2016-07-28
November, 2015	FDA 483	Cetylite Industries, Inc. - Form 483, 2015-11-19
March, 2020	FDA 483	KVK-TECH, INC. - Form 483, 2020-03-13
October, 2018	EIR	TPM Laboratories, Inc. - EIR, 2018-10-16
March, 2019	FDA 483	Veranova, L.P. - Form 483, 2019-03-08
May, 2019	FDA 483	Teligent, Inc. - Form 483, 2019-05-20
April, 2017	FDA 483	InvaTech Pharma Solutions LLC - Form 483, 2017-04-04

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more